<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>gene editing in neurodegenerative disorders &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/gene-editing-in-neurodegenerative-disorders/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Wed, 29 Jul 2026 17:34:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>gene editing in neurodegenerative disorders &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>In vivo CRISPR base editing for treatment of Huntington’s disease</title>
		<link>https://scienmag.com/in-vivo-crispr-base-editing-for-treatment-of-huntingtons-disease/</link>
		
		<dc:creator><![CDATA[Juliet Wilcox]]></dc:creator>
		<pubDate>Wed, 29 Jul 2026 17:34:07 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[advancements in neurogenetic therapies]]></category>
		<category><![CDATA[biomedical engineering in neurogenetics]]></category>
		<category><![CDATA[CRISPR technology in Huntington’s disease]]></category>
		<category><![CDATA[CRISPR-based gene correction in vivo]]></category>
		<category><![CDATA[gene editing in neurodegenerative disorders]]></category>
		<category><![CDATA[genome editing for hereditary neurological disorders]]></category>
		<category><![CDATA[Huntington’s disease genetic mutation targeting]]></category>
		<category><![CDATA[in vivo CRISPR base editing for Huntington’s disease treatment]]></category>
		<category><![CDATA[in vivo gene therapy strategies]]></category>
		<category><![CDATA[molecular mechanisms of Huntington’s disease]]></category>
		<category><![CDATA[targeted genetic therapy for Huntington’s]]></category>
		<category><![CDATA[therapeutic potential of CRISPR in neurodegeneration]]></category>
		<guid isPermaLink="false">https://scienmag.com/in-vivo-crispr-base-editing-for-treatment-of-huntingtons-disease/</guid>

					<description><![CDATA[Shirguppe, S., Gapinske, M., Swami, D. et al. In vivo CRISPR base editing for treatment of Huntington’s disease. Nat. Biomed. Eng (2026). https://doi.org/10.1038/s41551-026-01747-y https://doi.org/10.1038/s41551-026-01747-y]]></description>
										<content:encoded><![CDATA[<p><img decoding="async" src="https://media.springernature.com/w290h158/springer-static/image/art%3A10.1038/s41551-026-01747-y/MediaObjects/41551_2026_1747_Fig1_HTML.png" /></p>
<p class="c-bibliographic-information__citation">Shirguppe, S., Gapinske, M., Swami, D. <i>et al.</i> In vivo CRISPR base editing for treatment of Huntington’s disease.<br />
                    <i>Nat. Biomed. Eng</i>  (2026). https://doi.org/10.1038/s41551-026-01747-y</p>
<p><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41551-026-01747-y</span></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">175458</post-id>	</item>
	</channel>
</rss>
